These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7737842)

  • 1. Congenital diaphragmatic hernia.
    Fitzsimons R; Piracha M
    Ir Med J; 1995; 88(1):34. PubMed ID: 7737842
    [No Abstract]   [Full Text] [Related]  

  • 2. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surfactant therapy in newborns with hyaline membrane disease].
    Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing surfactant products.
    Prevost RR
    Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
    [No Abstract]   [Full Text] [Related]  

  • 5. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
    Narang A; Kumar P; Dutta S; Kumar R
    Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729
    [No Abstract]   [Full Text] [Related]  

  • 6. OSIRIS trial.
    Tarnow-Mordi W
    Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    Wyble L; Santeiro ML
    Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 9. On surfactant replacement therapy with Exosurf.
    Courtney SE
    Pediatr Pulmonol; 1992 May; 13(1):60-1. PubMed ID: 1589317
    [No Abstract]   [Full Text] [Related]  

  • 10. The acute respiratory distress syndrome.
    Matthay MA
    N Engl J Med; 1996 May; 334(22):1469-70. PubMed ID: 8618587
    [No Abstract]   [Full Text] [Related]  

  • 11. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
    Doig C
    JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
    [No Abstract]   [Full Text] [Related]  

  • 12. Nebulized synthetic surfactant in reperfusion injury after single lung transplantation.
    Strüber M; Cremer J; Harringer W; Hirt SW; Costard-Jäckle A; Haverich A
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):563-4. PubMed ID: 7637383
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of congenital diaphragmatic hernia.
    Nobuhara KK; Wilson JM
    Semin Pediatr Surg; 1996 Nov; 5(4):234-42. PubMed ID: 8936652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of institutional differences on study of surfactant in two centers.
    Etches PC; Peliowski A; Finer NN; Tierney AJ
    J Pediatr; 1991 Jul; 119(1 Pt 1):162-3. PubMed ID: 2066853
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Oct; 264(14):1802. PubMed ID: 2169534
    [No Abstract]   [Full Text] [Related]  

  • 17. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of ARDS with two doses of synthetic surfactant.
    Heikinheimo M; Hynynen M; Rautiainen P; Andersson S; Hallman M; Kukkonen S
    Chest; 1994 Apr; 105(4):1263-4. PubMed ID: 8162762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants.
    Sitler CG; Turnage CS; McFadden BE; Smith EO; Adams JM
    J Perinatol; 1993; 13(3):197-200. PubMed ID: 8345382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving survival of neonates with isolated congenital diaphragmatic hernia.
    Osiovich HC
    Indian Pediatr; 2004 Nov; 41(11):1138-42. PubMed ID: 15591664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.